Shire sells cancer drugs to Servier for US$2.4 billion as Takeda circles
LONDON: Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for US$2.4 billion.
The deal suggests there is value locked up within Shire's portfolio - despite a ...
Wall Street lobby groups urged U.S. policy makers and regulators to revamp rules to encourage more initial public offerings and to reduce the regulatory cost of staying public, in a white paper issued on Thursday.
SAN FRANCISCO: Internet colossus Amazon on Thursday (Apr 26) reported that its quarterly profit more than doubled on soaring revenue from online commerce and cloud services.
Amazon said it earned US$1.6 billion in the first three months of this year on revenue that soared to US$51 billion from US ...
U.S. stock index futures pointed to a strong open for the tech-heavy Nasdaq on Thursday as a slew of upbeat earnings from Facebook and Qualcomm helped set aside worries over rising U.S. bond yields and corporate costs.